Exit-value calculator

What could your practice be worth?

Compare three paths side by side — a private sale, a single DSO sale, and a staged doctor-owned ESOP whose multiple is size-aware and grows as the group scales. Adjust every assumption; nothing is saved and nothing here is an offer.

$2.00M
30%
Advanced assumptions

$5.72M≈ +$2.42M vs a DSO sale · +$4.32M vs a private sale — illustrative

Private sale

$1.40M

≈70% of collections

DSO sale

$3.30M

≈5.5× EBITDA, single practice

Doctor-owned ESOP

$5.72M

size-aware, staged

Private sale$1.40M
DSO sale$3.30M
Doctor-owned ESOP (staged)$5.72M
Bite 1 · 30% @ 7.4×$1.33M
Bite 2 · 30% @ 7.9×$1.70M
Bite 3 · 40% @ 7.8×$2.69M

Potential §1042 tax deferral: $1.72M — capital-gains tax that may be deferred (not eliminated) if you and the sale qualify (generally a C-corp, ≥30% sold, reinvested in qualified replacement property). Not tax advice.

Retained-equity “second payday”: $1.34M — an illustrative later value of the equity you keep in the group. Hypothetical.

EBITDA $600K = $2.00M × 30% · staged multiples 7.4× → 7.9× → 7.8× · your-EBITDA (conservative) model.

Illustrative educational estimate only — not an offer or solicitation of securities, and not tax, legal, investment, or valuation advice. Actual value is determined by an independent third-party appraisal. Individual results vary; projections are hypothetical and not guaranteed. See our disclaimer and how the ESOP works.

See this modeled for your practice →

How the estimate works

Transparent by design.

Size-aware multiples

EBITDA (collections × margin) is valued on a curve that reflects 2026 dental multiple tiers — roughly 5–8× for a single practice up to 10–12×+ for platform-grade groups. A DSO single sale is shown at ≈5.5× EBITDA and a private sale at ≈70% of collections.

Staged “bites”

The ESOP path sells your equity in stages. Between stages the group grows, so later tranches are valued off a larger, higher-multiple company. The default is the conservative “your-practice-only” model; a “group platform scale” model is available and clearly labeled.

§1042 tax deferral

On a qualifying C-corp ESOP sale of ≥30%, a selling owner may elect IRC §1042 todefer (not eliminate) capital-gains tax by reinvesting in qualified replacement property. The figure shown is an illustration of timing, not tax advice.

Retained equity

You don’t have to sell everything. The “second payday” line illustrates the later value of the equity you keep in the group. It’s hypothetical and never added to the headline number.

This tool is an illustrative educational estimate only — not an offer or solicitation of securities, and not tax, legal, investment, or valuation advice. Actual value is determined by an independent third-party appraisal. See our disclaimer andhow the ESOP works, then tell us you’re interested.